SANDRI, Gilda
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 16.674
NA - Nord America 7.383
AS - Asia 4.547
SA - Sud America 661
AF - Africa 109
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 6
Totale 29.417
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 12.914
US - Stati Uniti d'America 7.187
CN - Cina 1.484
SG - Singapore 1.402
GB - Regno Unito 1.296
HK - Hong Kong 583
BR - Brasile 527
NL - Olanda 449
DE - Germania 365
SE - Svezia 363
VN - Vietnam 277
FR - Francia 224
RU - Federazione Russa 203
FI - Finlandia 182
TR - Turchia 172
UA - Ucraina 170
KR - Corea 146
ID - Indonesia 112
CA - Canada 102
IN - India 79
CH - Svizzera 71
ES - Italia 71
AR - Argentina 61
MX - Messico 61
JP - Giappone 59
BG - Bulgaria 58
IE - Irlanda 57
PL - Polonia 45
AT - Austria 41
ZA - Sudafrica 40
BD - Bangladesh 34
AU - Australia 30
BE - Belgio 30
MY - Malesia 25
MA - Marocco 23
NO - Norvegia 23
IQ - Iraq 22
IR - Iran 21
PK - Pakistan 20
RO - Romania 17
CZ - Repubblica Ceca 16
CO - Colombia 15
EG - Egitto 15
PE - Perù 15
TW - Taiwan 15
AE - Emirati Arabi Uniti 14
LT - Lituania 13
MT - Malta 13
VE - Venezuela 12
EC - Ecuador 11
PH - Filippine 11
GR - Grecia 10
IL - Israele 10
PT - Portogallo 9
SA - Arabia Saudita 9
KE - Kenya 8
TH - Thailandia 8
AL - Albania 7
BZ - Belize 7
CL - Cile 7
NZ - Nuova Zelanda 7
PY - Paraguay 7
TN - Tunisia 6
BH - Bahrain 5
GT - Guatemala 5
KZ - Kazakistan 5
MK - Macedonia 5
AZ - Azerbaigian 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
HN - Honduras 4
HU - Ungheria 4
KG - Kirghizistan 4
AM - Armenia 3
BY - Bielorussia 3
DZ - Algeria 3
LV - Lettonia 3
NP - Nepal 3
OM - Oman 3
SN - Senegal 3
BA - Bosnia-Erzegovina 2
DK - Danimarca 2
DM - Dominica 2
EU - Europa 2
JM - Giamaica 2
JO - Giordania 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LU - Lussemburgo 2
NI - Nicaragua 2
PA - Panama 2
RE - Reunion 2
RS - Serbia 2
SM - San Marino 2
SS - ???statistics.table.value.countryCode.SS??? 2
SY - Repubblica araba siriana 2
TZ - Tanzania 2
UZ - Uzbekistan 2
YT - Mayotte 2
A1 - Anonimo 1
Totale 29.395
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.179
Rome 1.176
Milan 1.049
Singapore 902
Southend 872
Ashburn 657
Hefei 655
Hong Kong 577
Fairfield 428
Naples 425
Chandler 408
Bologna 320
Florence 305
Turin 276
Woodbridge 258
Jacksonville 253
Houston 245
London 243
Bari 204
Los Angeles 200
Nyköping 199
Dearborn 196
Ann Arbor 180
Wilmington 170
Beijing 161
Seattle 152
Chicago 150
Modena 145
Parma 139
Catania 137
Seoul 135
Genoa 133
Palermo 124
Cambridge 111
New York 109
Helsinki 106
Ho Chi Minh City 101
Verona 100
Izmir 92
Jakarta 90
Brescia 86
The Dalles 84
Padova 83
Moscow 81
Cagliari 75
São Paulo 73
Munich 71
Pescara 71
Reggio Emilia 68
Shanghai 65
Princeton 64
San Diego 59
Livorno 57
Trieste 57
Sofia 56
Buffalo 55
Hanoi 55
Salt Lake City 54
Council Bluffs 48
Dallas 48
Vicenza 48
Rimini 47
Trento 47
Eugene 44
San Jose 43
Tokyo 40
Perugia 37
Frankfurt am Main 36
Tampa 36
Bremen 35
Elk Grove Village 35
Kent 34
Mexico City 34
Ancona 33
Des Moines 33
Redwood City 32
Boardman 29
Dublin 29
Ottawa 29
Salerno 29
Venice 29
Monza 28
Ovada 28
Toronto 28
Taranto 27
Valencia 27
Bergamo 26
Orem 26
Stockholm 26
Messina 25
Warsaw 25
Columbus 24
Paris 24
Treviso 24
Nuremberg 23
Ankara 22
Brussels 22
Lappeenranta 22
Pavia 22
Phoenix 22
Totale 15.902
Salva come PNG Salva come JPEG
Nome #
Farmaci biologici e rischio oncologico 4.251
Tempi di sospensione dei farmaci biologici nello switch terapeutico e nella programmazione degli interventi chirurgici 4.111
L’infezione da papilloma virus umano (HPV) nei pazienti con artrite reumatoide trattati con farmaci biologici 3.570
Farmaci biologici e infezione tubercolare 508
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 393
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 360
Farmaci biologici e tematiche relative alla cardiopatia ischemica e all’insufficienza cardiaca 338
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 306
Biological Therapy and Risk of Malignancies: A Literature Review 305
Frequency and Results of Cryoglobulin Retesting in 4,963 Patients: Comment on the Article by Kolopp-Sarda et al 292
Non HCV-related mixed cryoglobulinemia 291
INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS) 280
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 277
Cryoglobulin evaluation: analysis of intra-laboratory and inter-laboratory variability 271
The discrepancy between clinical and ultrasonographic remission in rheumatoid arthritis is not related to therapy or autoantibody status. 267
La legislazione del dolore e la sua applicazione in Italia: pregi e difetti 266
Large Vessel Vasculitis Occurring in Rheumatoid Arthritis Patient under Anti-TNF Therapy 265
Beyond cat scratch disease: a case report of bartonella infection mimicking vasculitic disorder 239
EULAR guidelines on ANCA-associated vasculitis in the real life 231
ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA): THE RELATIONSHIP BETWEEN SEX, AGE AND ANTIGENIC SPECIFICITIES 228
EXPERIMENTAL USE OF 3D PRINTING TECHNOLOGY FOR THE CONSTRUCTION OF DEVICES AS INTEGRATION OF OCCUPATIONAL THERAPY INTERVENTION WITH RHEUMATOID ARTHRITIS PATIENTS (RA) 227
ANTI - TUMOR NECROSIS FACTOR ALPHA (ANTI-TNF) DRUGS IN RHEUMATOID ARTHRITIS: COMPARISON ON DISEASE MANAGEMENT BEFORE AND AFTER THE INTRODUCTION OF THESE BIOLOGICAL DRUGS IN MODENA, ITALY 223
Epstein-barr virus reactivation after infliximab in rheumatoid arthritis: a case report. 222
L’uso dei farmaci biologici durante la gravidanza e l’allattamento 219
Salivary 1H-NMR Metabolomics in Primary Sjögren Syndrome. Preliminary Results of a Pilot Case-Control Study 218
Ultrasonography in the diagnosis and management of patients with inflammatory arthritides 217
Interstitial lung disease is associated to infections of lower respiratory tract in immunocompromised rheumatoid arthritis patients 215
Early Occupational Therapy Intervention: Patients’ Occupational Needs 215
Immunodeficiency and autoimmune phenomena in female hyper-IgM syndrome 211
The prevalence of asymptomatic early sacroiliitis in Crohn’s disease patients: The single experience of an Italian tertiary care centre 209
Non-Hodgkin Lymphoma in Psoriatic Arthritis Treated with Sequential, Multiple Anti-TNF-α Agents: A Case Report 207
Sanitary costs of osteoarthritis 206
RETENTION RATE OF ADALIMUMAB AND ABP 501 IN THE TREATMENT OF A LARGE COHORT OF PATIENTS WITH INFLAMMATORY ARTHRITIS: A REAL LIFE RETROSPECTIVE ANALYSIS 205
Le crioglobuline miste: epidemiologia, clinica ed eziopatogenesi. Contributo personale. 202
INTERSTITIAL LUNG DISEASE IS ASSOCIATED TO INFECTIONS OF LOWER RESPIRATORY TRACT IN IMMUNOCOMPROMISED RHEUMATOID ARTHRITIS PATIENTS 202
COMPLEMENT DEPLETION IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOCILIZUMAB: A MARKER OF CLINICAL EFFICACY? 198
Photobiomodulation Therapy: A New Light in the Treatment of Systemic Sclerosis Skin Ulcers 194
Indicazioni chirurgiche alla artrodesi totale di polso nei pazienti affetti da artrite reumatoide. 193
PREVALENCE OF ULTRASOUND ABNORMALITIES IN PATIENTS WITH PSORIATIC ARTHRITIS IN A CLINICAL PHASE OF MINIMAL DISEASE ACTIVITY UNDER ANTI-TNF TREATMENT 193
HCV associated cryoglobulinemic vasculitis 192
Adalimumab and ABP 501 in the Treatment of a Large Cohort of Patients with Inflammatory Arthritis: A Real Life Retrospective Analysis 189
Tocilizumab for the treatment of patients with rheumatoid arthritis and interstitial lung diseases: a case series 184
Metabolic Profile of Whole Unstimulated Saliva in Patients with Sjögren's Syndrome 183
On- and off-label use of rituximab in rheumatic diseases 178
EXPERIENCE OF MULTIDISCIPLINARY TEAM FOR COMPLEX HAND FUNCTION PROBLEMS AT THE RHEUMATOLOGY OUTPATIENT CLINIC OF MODENA 175
NATURAL HISTORY OF CRYOGLOBULINEMIA FROM 2000 TO 2018 FROM THE LABORATORY POINT OF VIEW: AN ANALYSIS OF CRYOGLOBULIN CHARACTERISTICS IN A SINGLE CENTER. 175
Risankizumab e Upadacitinib nel Trattamento dell'Artrite Psoriasica: Meccanismi Diversi, Obiettivo Comune 175
UTILITY OF A SELF ADMINISTERED QUESTIONNAIRE AS A TOOL FOR SCREENING JOINT INVOLVEMENT UNDERWAY PSORIASIS 169
The predictive role of the TAPSE/sPAP ratio for cardiovascular events and mortality in systemic sclerosis with pulmonary hypertension 168
Patient characteristics of HCV-negative mixed cryoglobulinemia (MC) in Italy and Holland 167
Efficacia e sicurezza delle vaccinazioni anti-influenza e anti-pneumococco nei pazienti con artrite reumatoide trattati con farmaci biologici 167
Assessing hand grasp in patients with systemic sclerosis using the 16-grasp test: Preliminary results from a multidisciplinary study group 166
The New Test for Monitoring Infliximab Therapy: From Laboratory to Clinical Practice 165
Does early arthritis clinic organisation improve outcomes? What evidence is there? A systematic review 164
Predictors of DAPSA Response in Psoriatic Arthritis Patients Treated with Apremilast in a Retrospective Observational Multi-Centric Study (2023-02-07) 162
Farmaci biologici ed epatiti da virus B e C 161
Baseline Ultrasound Assessment Improves the Response to Apremilast in Patients with Psoriatic Arthritis: Results from a Multicentre Study 156
ORAL MANIFESTATIONS IN SYSTEMICSCLEROSIS: CLINICAL EVALUATION OF APERSONAL CASE SERIES OF 13 SCLERODERMAPATIENTS 155
Detection of autoimmunity in early primary Epstein-Barr virus infection by Western blot analysis 153
Efficacy and Drug Survival after Switching from Etanercept to the Biosimilar SB4: A Real-Life Long-Term Study 151
Promising use of filgotinib in patients affected by systemic sclerosis: Preliminary data from a case series of 5 patients 147
THE PREDICTIVE ROLE OF THE TAPSE/sPAP RATIO FOR CARDIOVASCULAR EVENTS AND MORTALITY IN SYSTEMIC SCLEROSIS COMPLICATED BY PULMONARY HYPERTENSION 144
IS THERE A DISSOCIATION BETWEEN CLINICAL REMISSION AND ULTRASONOGRAPHIC ASSESSMENT IN RHEUMATOID ARTHRITIS? 144
Apremilast retention rate in clinical practice: observations from an Italian multi-center study 143
Cryoproteinemia: new frontiers for clinicians and the laboratory 142
Cryofibrinogen: A possibile risk factor in systemic sclerosis 139
Analysis of cryoproteins with a focus on cryofibrinogen: a study on 103 patients 139
Endothelial Dysfunction in Acute Hepatic Porphyrias 139
Ultrasonographic and clinical assessment of peripheral enthesitis and arthritis in an Italian cohort of inflammatory bowel disease patients 138
Diagnosi di crioproteinemia: preziosa collaborazione tra laboratorio e clinica per la corretta gestione di una patologia rara 137
Susceptibility to COVID-19 in Patients Treated With Antimalarials: A Population-Based Study in Emilia-Romagna, Northern Italy 136
EFFICACY OF CERTOLIZUMAB PEGOL FOR DISEASE CONTROL OF PATIENTS AFFECTED BY ENTEROPATHIC SPONDYLARTHRITIS FOLLOWED BY THE JOINT GASTRO-RHEUMATOLOGICAL CLINIC 135
ACCERTAMENTO DELLA DISABILITÀ NELLE MALATTIE REUMATOLOGICHE (EX L.R. N.4 DEL 19 FEBBRAIO 2008) PROPOSTA DI PROTOCOLLO ORGANIZZATIVO 130
The management of large vessel vasculitides 127
A CALL FOR A COMPREHENSIVE ROLE DEFINITION OF THE STUDY COORDINATOR IN RHEUMATOLOGICAL CLINICAL STUDIES 124
Analysis of survival rate and persistence predictors of baricitinib in real-world data from a large cohort of rheumatoid arthritis patients 121
SAFETY AND EFFICACY OF INTRAVENOUS ILOPROST IN THE TREATMENT AND PREVENTION OF SCLERODERMA-RELATED DIGITAL ULCERS 119
Correction: PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability (Modern Pathology, (2020), 33, 7, (1398-1409), 10.1038/s41379-020-0497-0) 119
PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability 114
JANUS KINASES INHIBITORS IN CLINICAL PRACTICE IN ITALY. RESULTS FROM A SINGLE CENTER EXPERIENCE 113
PROBABILITÀ DI SIEROCONVERSIONE DEL TEST QUANTIFERON DURANTE LA TERAPIA BIOTECNOLOGICA: DATI PRELIMINARI DI UNO STUDIO RETROSPETTIVO CONDOTTO PRESSO L’ARTHRITIS CLINIC DELL’AZIENDA OSPEDALIERO-UNIVERSITARIA POLICLINICO DI MODENA 111
A consensus-based approach on the management of patients with both psoriasis and psoriatic arthritis in the dermatological and rheumatological settings in Italy: The ADOI PSO-Amore Project 110
CONFRONTO TRA STRATEGIE DI TERAPIA AVANZATA DI 2° E 3° LINEA NELLA ARTRITE PSORIASICA: RISULTATI PRELIMINARI DALLO STUDIO OSSERVAZIONE RETROSPETTIVO BIRRA 105
Factors associated of long-term retention rate of Janus kinase inhibitors in a multi-failure rheumatoid arthritis population 104
L’IPERTENSIONE POLMONARE: DALLE NUOVE LINEE GUIDA ALLA PRATICA CLINICA 102
Upadacitinib: One More Option in the Treatment of Patients with Rheumatoid Arthritis and Crohn's Disease 102
CYCLING VS SWAP TNFi AND IL17i IN PSORIATIC ARTHRITIS: RESULTS FROM THE BIRRA RETROSPECTIVE OBSERVATIONAL STUDY 101
Buerger's disease or thromboangiitis obliterans: description of two cases 97
Cycling versus swapping strategieswith TNF-α inhibitors and IL-17 inhibitors in psoriatic arthritis in clinical practice 96
DIFFERENCES BETWEEN SELECTIVE AND UNSELECTIVE JAKi: RESULTS FROM A MULTICENTRIC, REAL LIFE STUDY CARRIED OUT ON PATIENTS WITH RA 96
Role of COVID-19 in the progression of scleroderma interstitial lung disease and new onset pulmonary hypertension: a challenging case report. 96
Secondary cryofibrinogenemia is related to more severe microangiopathic involvement in systemic sclerosis: results from a retrospective observational study. 96
POS0604 JAKi’S SURVIVAL RATE AND PREDICTORS OF DISCONTINUATION IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS 95
Secondary cryofbrinogenemia is related to more severe microangiopathic involvement in systemic sclerosis: results from a retrospective observational study 92
Impact of the 2023 ACR/EULAR Classification Criteria on START2 Antiphospholipid Registry 88
Multicenter observational study on the efficacy of selective Janus Kinase-1 inhibitor upatacitinib in rheumatoid arthritis 88
Clinical and ultrasonographic predictors of disease activity after TNF-α inhibitor spacing in patients with psoriatic arthritis 86
The importance of body image and aesthetic medicine in systemic sclerosis 84
Influence of safety warnings on the prescribing attitude of JAK 2inhibitors for rheumatoid arthritis in Italy 81
Effectiveness and Predictors of Long-Term Treatment Response to Tofacitinib in Rheumatoid Arthritis Cohort: General Analysis and Focus on High-Cardiovascular-Risk Subgroup— AMulticenter Study 80
Totale 29.140
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.786
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.786
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021827 0 0 0 0 0 0 170 155 114 209 94 85
2021/20221.414 65 123 69 109 54 90 59 87 212 72 277 197
2022/20232.719 184 186 171 161 194 293 152 259 313 177 312 317
2023/20245.535 318 249 393 460 512 413 562 550 273 595 618 592
2024/20259.128 570 415 411 676 1.509 1.064 685 627 1.009 559 794 809
2025/20266.075 832 616 1.051 1.492 1.377 693 14 0 0 0 0 0
Totale 29.607